HDFC Low Duration Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

HDFC Low Duration Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

HDFC Low Duration Fund - Direct (G)

6.29%

stock2

Nippon India Pharma Fund - Direct (G)

7.4%

Loading chart...

About Fund

HDFC Bank Limited & Citibank N.A

Computer Age Management Services Pvt. Ltd.

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Moderate Risk

100

18338.03

0.15

67.0654

January 1, 2013

0

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

6.72 %

7.5 %

6.29 %

14.01 %

19.35 %

7.4 %

Anil Bamboli

B.Com, ICWA, MMS, CFA

Collectively over 24 years of experience in Fund Management and Research, Fixed Income dealing. July 25, 2003 till date: HDFC Asset Management Company Limited. May 1994 - July 2003: SBI Funds Management Pvt. Ltd. Last Position held - Asst. Vice President

Anupam Joshi

P.G.Diploma in Business mnagement.

He has Over 13 years of experience. In his last assignment with Principal PNB AMC he involved in Portfolio Management & Dealing from November 2005 - August 2008.prior to this he worked in ICAP India Private Ltd as a Dealer from May 2003 - November 2005.

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right